YTHDF1 promotes the viability and self‑renewal of glioma stem cells by enhancing LINC00900 stability
International Journal of Oncology · 2024
DOI: 10.3892/ijo.2024.5641 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Oncology, 2024. Verfasst von Yuanhai Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, Jiangsu 214000, P.R. China. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma, MicroRNAs, Neoplastic Stem Cells. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, Wuxi, Jiangsu 214000, P.R. China.
- Department of Neurosurgery, Medical School of Nantong University, Nantong University, Nantong, Jiangsu 226019, P.R. China.
- Department of Neurosurgery, Wuxi No. 2 People's Hospital, Affiliated Wuxi Clinical College of Nantong University, Wuxi, Jiangsu 214000, P.R. China.
Zitieren
APA
Zhang, Y., Zhu, Y., Zhang, Y., Liu, Z., & Zhao, X. (2024). YTHDF1 promotes the viability and self‑renewal of glioma stem cells by enhancing LINC00900 stability. International Journal of Oncology. https://doi.org/10.3892/ijo.2024.5641
Vancouver
Zhang Y, Zhu Y, Zhang Y, Liu Z, Zhao X. YTHDF1 promotes the viability and self‑renewal of glioma stem cells by enhancing LINC00900 stability. International Journal of Oncology. 2024. doi:10.3892/ijo.2024.5641
BibTeX
@article{Zhang2024,
author = {Zhang, Yuanhai and Zhu, Yi and Zhang, Yating and Liu, Zixiang and Zhao, Xudong},
title = {YTHDF1 promotes the viability and self‑renewal of glioma stem cells by enhancing LINC00900 stability},
journal = {International Journal of Oncology},
year = {2024},
doi = {10.3892/ijo.2024.5641}
}
EUVIMED